Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the extent of cyclosporine microemulsion dose
reduction required to maintain stable renal function in maintenance cardiac transplant
recipients, after initiation of everolimus.